Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Personalized Breast Cancer Trial Advances 7 Drugs

Laura Esserman

A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA. . . . → Read More: Personalized Breast Cancer Trial Advances 7 Drugs

A.I. to Identify Treatment Drivers for Colorectal Cancer

Data and person graphic

A study will soon get underway with artificial intelligence and simulation analyzing data from clinical trials to identify factors behind responses to a treatment for colorectal cancer. . . . → Read More: A.I. to Identify Treatment Drivers for Colorectal Cancer

Machine Learning Detects More Cancer Mutations

Population genetics

Medical researchers and data scientists developed a system for analyzing genomic data from cancer patients that accurately detects more cancer-causing mutations than other current techniques. . . . → Read More: Machine Learning Detects More Cancer Mutations

Genentech Gains Modular Engineered Antibodies in $5B Deal

Natural killer cell

A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers. . . . → Read More: Genentech Gains Modular Engineered Antibodies in $5B Deal

A.I., Imaging Shown to Predict Immunotherapy Success

Computational biology illustration

Researchers in France developed a system for computing data from CT scans and genomic analysis to predict the success for therapies that invoke the immune system in patients with solid-tumor cancers. . . . → Read More: A.I., Imaging Shown to Predict Immunotherapy Success

M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency

U.S. and Texas flags

M.D. Anderson Cancer Center and a spin-off enterprise formed earlier this month are receiving nearly $50 million in grants from Texas’s state cancer prevention and research agency. . . . → Read More: M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency

Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies

Mountain bluebird

Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types. . . . → Read More: Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies

Trial Testing Cancer Treatment Delivery Compound

Erkki Ruoslahti

A compound designed to help cancer therapies better penetrate and kill solid tumors is being tested in its first clinical trial among patients with pancreatic cancer. . . . → Read More: Trial Testing Cancer Treatment Delivery Compound

Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million

Magnolia Neuroscience

A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy. . . . → Read More: Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million

Cancer Drug Delivery Through Milk Particles Under Study

Cattle

A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions. . . . → Read More: Cancer Drug Delivery Through Milk Particles Under Study